The Danish Research Center for Lung Cancer will promote collaboration between clinic and research communities on patient-close research in lung cancer. The purpose is to improve the diagnosis and treatment of lung cancer while focusing on patients’ quality of life.
Lung cancer is the cancer disease in Denmark that most patients die from. Despite significant improvements in the prognosis of lung cancer patients over the past 10-15 years, lung cancer today still accounts for 25% of all cancer deaths. Lung cancer is therefore a well-chosen area of action to reduce the overall cancer mortality rate in Denmark.
The Danish Lung Cancer Group (DLCG) has for the past 25 years been responsible for quality monitoring and development in diagnostics, treatment and follow-up of patients with lung cancer, and through this has contact with a wide network of clinicians throughout Denmark. With the establishment of the Danish Research Center for Lung Cancer, this network and collaboration is further developed by creating a national platform for the full range of research from early diagnosis to improved surgery and oncology treatment for rehabilitation and palliative care.
The research center has the following objectives:
- Promote collaboration between clinic and research environments and improve diagnosis and treatment of lung cancer
- To build a unifying national platform operating at the highest international level
- To create an effective framework for optimal introduction of evidence-based treatment of lung cancer in Denmark
- In the long term, be able to offer participation in clinical trials to all relevant patients with lung cancer
The Danish Cancer Society’s Scientific Committee, as the evaluation committee for the Cancer Cancer 2016 pool “Research in lung cancer”, has provided funding for a total project period for 5 years running from September 1, 2019 – August 31, 2024.
The Board of Directors of the Danish Research Center for Lung Cancer has subsequently granted grants for these research projects.
